MCM
BOLD

Moore Capital Management’s Audentes Therapeutics, Inc BOLD Stock Holding History

Moore Capital Management’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-150,000
Closed -$8.98M – 304
2019
Q4 		$8.98M Buy
+150,000
New +$5.63M 0.29% 93

Moore Capital Management's BOLD Position: Q1 2020 in Review

Moore Capital Management sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 150,000 shares — an estimated $8.98M sold.

Moore Capital Management first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $8.98M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Moore Capital Management reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Moore Capital Management sold 150,000 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $8.98M.
  • Moore Capital Management first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
  • Moore Capital Management's Audentes Therapeutics, Inc position peaked at $8.98M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Moore Capital Management's 13F filing for Q1 2020, filed 15 May 2020.